investor
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 2, 2016
Homology Medicines
|
Series A | $43.50M | Alternative Medicine | — |
Mar 23, 2016
Quanterix
|
Series D | $46M | Biotechnology | Yes |
Jan 19, 2016
Twist Bioscience
|
Series D | $61M | Biotechnology | — |
ARCH Overage Fund has had 3 exits. ARCH Overage Fund most notable exits include Twist Bioscience , Homology Medicines
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 30, 2018 | Twist Bioscience | IPO | Biotechnology | Detail |
Mar 27, 2018 | Homology Medicines | IPO | Alternative Medicine | Detail |
Dec 6, 2017 | Quanterix | IPO | Biotechnology | Detail |